These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 33551672)

  • 1. The COVID-19 puzzle: a global nightmare.
    Mahrosh HS; Mustafa G
    Environ Dev Sustain; 2021; 23(9):12710-12737. PubMed ID: 33551672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.
    Meo SA; Alhowikan AM; Al-Khlaiwi T; Meo IM; Halepoto DM; Iqbal M; Usmani AM; Hajjar W; Ahmed N
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2012-2019. PubMed ID: 32141570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in silico approach to target RNA-dependent RNA polymerase of COVID-19 with naturally occurring phytochemicals.
    Mahrosh HS; Mustafa G
    Environ Dev Sustain; 2021; 23(11):16674-16687. PubMed ID: 33841038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness.
    Ralph R; Lew J; Zeng T; Francis M; Xue B; Roux M; Toloue Ostadgavahi A; Rubino S; Dawe NJ; Al-Ahdal MN; Kelvin DJ; Richardson CD; Kindrachuk J; Falzarano D; Kelvin AA
    J Infect Dev Ctries; 2020 Jan; 14(1):3-17. PubMed ID: 32088679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection.
    Bhatti JS; Bhatti GK; Khullar N; Reddy AP; Reddy PH
    Mol Neurobiol; 2020 Nov; 57(11):4856-4877. PubMed ID: 32808122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development.
    Oves M; Ravindran M; Rauf MA; Omaish Ansari M; Zahin M; Iyer AK; Ismail IMI; Khan MA; Palaniyar N
    Pathogens; 2020 Nov; 9(12):. PubMed ID: 33255989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2.
    Gupta AK; Khan MS; Choudhury S; Mukhopadhyay A; Sakshi ; Rastogi A; Thakur A; Kumari P; Kaur M; Shalu ; Saini C; Sapehia V; Barkha ; Patel PK; Bhamare KT; Kumar M
    Front Microbiol; 2020; 11():1858. PubMed ID: 32849449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
    Akhtar N; Joshi A; Singh B; Kaushik V
    Infect Disord Drug Targets; 2021; 21(4):541-552. PubMed ID: 32957905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection.
    Costanzo M; De Giglio MAR; Roviello GN
    Curr Med Chem; 2022; 29(1):4-18. PubMed ID: 34355678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections.
    Schwartz DA; Graham AL
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32050635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.
    Havervall S; Marking U; Greilert-Norin N; Ng H; Gordon M; Salomonsson AC; Hellström C; Pin E; Blom K; Mangsbo S; Phillipson M; Klingström J; Hober S; Nilsson P; Åberg M; Thålin C
    EBioMedicine; 2021 Aug; 70():103523. PubMed ID: 34391088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review.
    Dash P; Mohapatra S; Ghosh S; Nayak B
    Front Pharmacol; 2020; 11():590154. PubMed ID: 33815095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 and COVID-19: How much do we know?
    Wang M; Liao Z
    Acta Virol; 2020; 64(3):288-296. PubMed ID: 32985201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review on Promising vaccine development progress for COVID-19 disease.
    Belete TM
    Vacunas; 2020; 21(2):121-128. PubMed ID: 32837460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.